Ledger.Open graph →
SEC Form D · filed April 19, 2016

Adgero Biopharmaceuticals Holdings, Inc

Offering
$15.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PRINCETON, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Tim P. Mcinerney · Princeton, NJDirectorRoman P. Perez-Soler · Princeton, NJDirectorSteve P. Rychnovsky · Princeton, NJExecDavid P. Hochman · Princeton, NJDirectorFrank P. Pilkiewicz · Princeton, NJExec · DirectorAllen P. Bloom · Princeton, NJDirectorRagan Young · Dallas, TXExec · DirectorDavid Dunn · Wilton, CTDirectorNicolai Wadstrom · San Francisco, CADirectorHelen L. Francis · Westport, CTExecRobert A. Granieri · New York, NYDirectorMichael A. Jenkins · New York, NYDirectorLinzy O. Scott · Atlanta, GADirectorLindsay Watson · Hamilton, BermudaDirectorMark Way · Hamilton, BermudaExec · DirectorAlastair Barbour · Edinburgh, United KingdomDirectorCarrie M. Bass · Dallas, TXDirectorRobert B. Knapp · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗